机构:[1]Department of Intensive Care Unit, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011 Hebei, China.临床科室重症医学科河北医科大学第四医院[2]Department of Emergency (Xiangjiang Hospital), The Third Hospital of Hebei Medical University, Shijiazhuang, 050051 Hebei, China.[3]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011 Hebei, China.河北医科大学第四医院科研中心医技科室
第一作者机构:[1]Department of Intensive Care Unit, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011 Hebei, China.
通讯作者:
通讯机构:[3]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011 Hebei, China.
推荐引用方式(GB/T 7714):
Li Juan,Yang Dong,Zhang Cong,et al.ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma[J].BIOMED RESEARCH INTERNATIONAL.2022,2022:5328192.doi:10.1155/2022/5328192.
APA:
Li Juan,Yang Dong,Zhang Cong,Wei Sisi,Zhao Ruinian...&Shan Baoen.(2022).ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.BIOMED RESEARCH INTERNATIONAL,2022,
MLA:
Li Juan,et al."ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma".BIOMED RESEARCH INTERNATIONAL 2022.(2022):5328192